These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


306 related items for PubMed ID: 7668036

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III.
    Aggerbeck H, Wantzin J, Heron I.
    Vaccine; 1996 Sep; 14(13):1265-72. PubMed ID: 8961516
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity and safety of combined adsorbed low-dose diphtheria, tetanus and inactivated poliovirus vaccine (REVAXIS (®)) versus combined diphtheria, tetanus and inactivated poliovirus vaccine (DT Polio (®)) given as a booster dose at 6 years of age.
    Gajdos V, Soubeyrand B, Vidor E, Richard P, Boyer J, Sadorge C, Fiquet A.
    Hum Vaccin; 2011 May; 7(5):549-56. PubMed ID: 21441781
    [Abstract] [Full Text] [Related]

  • 5. Studies on the adequate composition of diphtheria and tetanus toxoids-with reference to the amounts of toxoids and aluminum adjuvant.
    Someya S, Mizuhara H, Murata R, Kurokawa M.
    Jpn J Med Sci Biol; 1981 Feb; 34(1):21-35. PubMed ID: 7265558
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Reduced immunogenicity of diphtheria and tetanus toxoids when combined with pertussis toxoid.
    Trollfors B, Taranger J, Lagergård T, Sundh V.
    Pediatr Infect Dis J; 2005 Jan; 24(1):85-6. PubMed ID: 15665717
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [A comparative evaluation of the immunological efficacy of ADPT vaccine and ADT-M anatoxin in the immunization of children against diphtheria and tetanus].
    Rusakova EV, Bezuglova MS, Vasil'eva VI, Frank KD, Panina GM.
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):52-5. PubMed ID: 1950266
    [Abstract] [Full Text] [Related]

  • 14. Capture EIA for determination of IgE to diphtheria and tetanus toxins in comparison to RIA.
    Wahren E, Bengtsson C, Björkstén B, Mark A, Granström M.
    Vaccine; 1998 Jul; 16(9-10):873-6. PubMed ID: 9682330
    [Abstract] [Full Text] [Related]

  • 15. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E, von Sonnenburg F, Sänger R, Abitbol V, Wolter JM, Schuerman LM.
    Vaccine; 2005 May 25; 23(28):3657-67. PubMed ID: 15882526
    [Abstract] [Full Text] [Related]

  • 16. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H.
    Verh K Acad Geneeskd Belg; 2000 May 25; 62(4):245-67. PubMed ID: 11004905
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The vaccination of children with allergic diseases with reduced doses of adsorbed DT-m anatoxin].
    Kostinov MP, Balabolkin II, Maksimova NM, Gervazieva VB, Egor'kov NA, Ovsiannikova IG, Lobanova AN.
    Pediatriia; 1991 May 25; (8):26-33. PubMed ID: 1762853
    [Abstract] [Full Text] [Related]

  • 19. [Use of adsorbed diphtheria-tetanus (DT) toxoid containing different doses of antigens in booster immunizations of children].
    Egor'kov NA, Moksimova NM, Platonova TV, Chebotareva SV, Lobanova AN.
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun 25; (6):47-52. PubMed ID: 2800793
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.